Amanda Pack, NP
Family · Athens, OHNPI 1609329085
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $12,175 of the $16,280 with a category attached, or 74.8%. AbbVie accounts for 95.4% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $9,709 and has fallen 69.7% since, to $2,938 in 2025. Among family clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 146 payments — averaging $111.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$16K
- Lundbeck LLC$321
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$269
- Otsuka America Pharmaceutical, Inc.$74
- Supernus Pharmaceuticals, Inc.$51
- Johnson & Johnson$19
- plus $16 from 1 others
What the payments were for
- Speaking & faculty fees$12,17575%
- Travel & lodging$1,68310%
- Food & beverage$2,37515%
- Education$470%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 122 | $15,531 |
| Lundbeck LLC | 13 | $321 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $269 |
| Otsuka America Pharmaceutical, Inc. | 2 | $74 |
| Supernus Pharmaceuticals, Inc. | 3 | $51 |
| Johnson & Johnson | 1 | $19 |
| Alkermes, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,280 in reported general payments places this provider in the 95th percentile of 6,812 family providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 177 | $287,635 |
| VraylarCariprazine Hcl | 182 | $261,348 |
| Lurasidone Hcl | 80 | $45,218 |
| LybalviOlanzapine/Samidorphan Malate | 13 | $18,398 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 239 | $16,727 |
| Aripiprazole | 112 | $13,443 |
| TrintellixVortioxetine Hydrobromide | 12 | $6,704 |
| Paliperidone ErPaliperidone | 31 | $6,600 |
| VyvanseLisdexamfetamine Dimesylate | 16 | $5,922 |
| Quetiapine Fumarate | 82 | $4,945 |
| Vilazodone Hcl | 33 | $3,923 |
| Clomipramine Hcl | 27 | $2,617 |
| Buspirone Hcl | 179 | $2,502 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 51 | $2,244 |
| Bupropion XlBupropion Hcl | 169 | $2,232 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $74 | $287,635177 claims |
| AbbVieVraylar | $15,531 | $261,348182 claims |
| Alkermes, Inc.Lybalvi | $16 | $18,39813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,812 family providers in Ohio.
Other family in Athens
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Florence StewartNew Albany$113K
- Kirt MunsonToledo$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.